Percheron Therapeutics Limited (ASX:PER)
Australia · Delayed Price · Currency is AUD 0.0040
-0.0010 (-20.00%)
Oct 1, 2026, 2:04 PM AEST
Percheron Therapeutics Market Cap
Percheron Therapeutics has a market cap or net worth of 7.29 million as of October 1, 2026. Its market cap has decreased by -32.96% in one year.
Market Cap
7.29M
Enterprise Value
3.27M
Revenue
843.60K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
ChartMarket Cap Chart
Since December 20, 2001, Percheron Therapeutics's market cap has decreased from 26.10M to 7.29M, a decrease of -72.07%. That is a compound annual growth rate of -5.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 7.29M | -25.52% |
| Dec 31, 2025 | 9.79M | 28.57% |
| Dec 31, 2024 | 7.61M | -85.69% |
| Dec 29, 2023 | 53.19M | -18.04% |
| Dec 30, 2022 | 64.90M | -50.23% |
| Dec 31, 2021 | 130.40M | 74.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medical Developments International | 49.01M |
| Syntara | 43.19M |
| Peak Processing | 21.26M |
| IDT Australia | 19.23M |
| Vitura Health | 12.59M |
| Epsilon Healthcare | 10.12M |
| ECS Botanics Holdings | 8.81M |
| Cann Group | 7.47M |